19763117|t|The Coalition Against Major Diseases: developing tools for an integrated drug development process for Alzheimer's and Parkinson's diseases.
19763117|a|Aiming to emulate the successful accelerated development of HIV/AIDS drugs, the Critical Path Institute (C-Path), in collaboration with the Engelberg Center for Health Care Reform at the Brookings Institution, has formed the Coalition Against Major Diseases (CAMD). Members include 6 nonprofit groups representing patients' interests, 15 leading pharmaceutical companies, the US Food and Drug Administration (FDA), the European Medicines Agency (EMEA), 2 institutes of the National Institutes of Health (NIH)-the National Institute on Aging (NIA) and the National Institute of Neurological Disorders and Stroke (NINDS)-and representatives from academia. The coalition's purpose is to transform the drug development paradigm for neurodegenerative diseases and serve as a model for other major diseases.
19763117	22	36	Major Diseases	Disease	MESH:D004830
19763117	102	138	Alzheimer's and Parkinson's diseases	Disease	MESH:D010300
19763117	200	208	HIV/AIDS	Disease	MESH:D015658
19763117	383	397	Major Diseases	Disease	MESH:D004830
19763117	399	403	CAMD	Disease	MESH:D000070604
19763117	454	462	patients	Species	9606
19763117	717	750	Neurological Disorders and Stroke	Disease	MESH:D009461
19763117	752	757	NINDS	Disease	MESH:D009461
19763117	868	894	neurodegenerative diseases	Disease	MESH:D019636
19763117	926	940	major diseases	Disease	MESH:D004830

